Go Back

Lightspeed China Partners

Lightspeed China Partners, a venture fund established in 2006, operates out of Shanghai, China. Specializing in Seed, Series A, and Series B stages, the fund concentrates on BioTech, Healthcare, Information Technology, Entertainment & Media sectors. Sam Shi is a key partner at Lightspeed China Partners, which has invested in 138 companies and has seen 10 successful exits. Portfolio companies include METiS Therapeutics and LeetCode. For more details, visit their website at www.lightspeedcp.com.

About

About

About

Bio

Lightspeed China Partners is a leading venture capital focusing on early-stage investments in China.

Location

Shanghai, China

Stage

Seed, Series A, Series B

Partner name

Sam Shi

Bio

Lightspeed China Partners is a leading venture capital focusing on early-stage investments in China.

Location

Shanghai, China

Stage

Seed, Series A, Series B

Partner name

Sam Shi

Fund

Fund

Fund

Fund Focus

BioTech, Healthcare, Information Technology, Entertainment & Media

Number of investments

138

Number of exits

10

Fund Type

Venture Fund

Portfolio Companies

METiS Therapeutics, LeetCode

Lightspeed China Partners

Lightspeed China Partners, a venture fund established in 2006, operates out of Shanghai, China. Specializing in Seed, Series A, and Series B stages, the fund concentrates on BioTech, Healthcare, Information Technology, Entertainment & Media sectors. Sam Shi is a key partner at Lightspeed China Partners, which has invested in 138 companies and has seen 10 successful exits. Portfolio companies include METiS Therapeutics and LeetCode. For more details, visit their website at www.lightspeedcp.com.

About

Bio

Lightspeed China Partners is a leading venture capital focusing on early-stage investments in China.

Location

Shanghai, China

Stage

Seed, Series A, Series B

Partner name

Sam Shi

Fund

Fund Focus

BioTech, Healthcare, Information Technology, Entertainment & Media

Number of investments

138

Number of exits

10

Fund Type

Venture Fund

Portfolio Companies

METiS Therapeutics, LeetCode